PURCHASE AGREEMENTPurchase Agreement • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
THIS PURCHASE AGREEMENT (“Agreement”) is made as of the 2nd day of February, 2016 by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”), Boyalife Investment Inc. (“Boyalife USA”), and Boyalife (Hong Kong) Limited (“Boyalife Hong Kong”). Boyalife USA and Boyalife Hong Kong are each referred to in this Agreement, individually, as an “Investor” and, together, as the “Investors”.
FORM OF GENERAL RELEASE OF CLAIMSGeneral Release of Claims • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This GENERAL RELEASE OF CLAIMS (this “Release”) is made and entered into as of [●], 2016 by and between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and [Sabby Healthcare Master Fund, Ltd. / Sabby Volatility Warrant Master Fund, Ltd.] (“Sabby”). The Company and Sabby are referred to herein, collectively, as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Consent, Repayment and Release Agreement (as defined below).
CONSENT, REPAYMENT AND RELEASE AGREEMENTConsent, Repayment and Release Agreement • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This CONSENT, REPAYMENT AND RELEASE AGREEMENT (this “Agreement”) is entered into as of February 2, 2016 (the “Effective Date”) by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”), Sabby Healthcare Master Fund, Ltd. (“Sabby Healthcare Fund”) and Sabby Volatility Warrant Master Fund, Ltd. (“Sabby Volatility Fund”, and together with Sabby Healthcare Fund, the “Sabby Parties”). The Company and the Sabby Parties are referred to herein, collectively, as the “Parties”.
SERIES A WARRANT AMENDMENTSeries a Warrant Amendment • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Series A Warrant Amendment (this “Amendment”) is entered into as of [●], 2016 (the “Effective Date”) by and between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and [Sabby Healthcare Master Fund, Ltd. / Sabby Volatility Warrant Master Fund, Ltd.] (“Sabby”). The Company and Sabby are referred to herein, collectively, as the “Parties”.
CESCA THERAPEUTICS INC. NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This Nomination and Voting Agreement (this “Agreement”) is made as of [●], 2016 by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”) Boyalife Investment Inc. (“Boyalife USA”), and Boyalife (Hong Kong) Limited (“Boyalife Hong Kong”). Boyalife USA and Boyalife Hong Kong are each referred to in this Agreement, individually, as an “Investor” and, together, as the “Investors”. The Company and the Investors are referred to herein collectively as, the “Parties”.
SECURITY AGREEMENTSecurity Agreement • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This Security Agreement (as amended, modified or otherwise supplemented from time to time, this “Security Agreement”) is made as of [●], 2016, by and between Cesca Therapeutics Inc., a Delaware corporation (together with its successors and assigns, the “Company”), and Boyalife Investment Inc. (the “Investor”).
